Reconsidering the Benefits of Osteoporosis Treatment: The Case of Bisphosphonates-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reconsidering the Benefits of Osteoporosis Treatment: The Case of Bisphosphonates

Published:2024-06 Issue:6 Volume:137 Page:476-478
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Goodman Christopher W.^ORCID

Publisher

Elsevier BV

Reference8 articles.

1. Effectiveness and safety of treatments to prevent fractures in people with low bone mass or primary osteoporosis: a living systematic review and network meta-analysis for the American College of Physicians;Ayers;Ann Intern Med,2023

2. Screening for osteoporosis to prevent fractures: US Preventive Services Task Force Recommendation Statement;Curry;JAMA,2018

3. Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures. Fracture Intervention Trial Research Group;Nevitt;Arch Intern Med,2000

4. Using alternative statistical formats for presenting risks and risk reductions;Akl;Cochrane Database Syst Rev,2011

5. Communicating absolute fracture risk reduction and the acceptance of treatment for osteoporosis;Ralston;Calcif Tissue Int,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3